Alps Advisors Inc. Buys Shares of 9,970 Semler Scientific Inc. (NASDAQ:SMLR)

Alps Advisors Inc. bought a new position in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 9,970 shares of the company's stock, valued at approximately $361,000. Alps Advisors Inc. owned 0.10% of Semler Scientific as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of the business. Kovitz Investment Group Partners LLC grew its position in shares of Semler Scientific by 2.2% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock worth $1,236,000 after purchasing an additional 501 shares in the last quarter. NewEdge Advisors LLC grew its holdings in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after buying an additional 557 shares in the last quarter. BNP Paribas Financial Markets purchased a new stake in Semler Scientific during the 4th quarter valued at approximately $30,000. Cambridge Investment Research Advisors Inc. raised its position in shares of Semler Scientific by 10.2% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock valued at $225,000 after buying an additional 576 shares during the last quarter. Finally, Jones Financial Companies Lllp purchased a new position in shares of Semler Scientific in the fourth quarter worth $34,000. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Price Performance

Semler Scientific stock traded up $0.53 during mid-day trading on Wednesday, reaching $42.71. 815,562 shares of the company's stock traded hands, compared to its average volume of 575,114. Semler Scientific Inc. has a 12-month low of $21.77 and a 12-month high of $81.56. The company has a quick ratio of 0.51, a current ratio of 0.52 and a debt-to-equity ratio of 0.59. The stock has a 50 day moving average of $37.89 and a two-hundred day moving average of $41.54. The company has a market cap of $584.61 million, a price-to-earnings ratio of -16.36 and a beta of 1.39.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%. The company had revenue of $8.84 million during the quarter.

Analysts Set New Price Targets

Several research firms recently weighed in on SMLR. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 target price for the company in a research note on Wednesday, July 9th. Benchmark started coverage on Semler Scientific in a research report on Tuesday, July 8th. They set a "buy" rating and a $101.00 price objective for the company. Finally, Wall Street Zen cut Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.